Abstract
Multimorbidity in Sub-Saharan Africa is under researched and includes distinct disease combinations to those seen in high income countries. The aim of this study was to determine the prevalence and distribution of multimorbidity in South Africa, as well as the associated individual, area-level and contextual factors. Multilevel logistic regression analyses were conducted on nationally representative 2016 South Africa Demographic Health Survey Data. The sample included 5,342 individuals (level 1) who completed the Adult Health questionnaire living in 691 neighbourhoods (level 2) from nine provinces (level 3). Multimorbidity was present in 44.6% of the study population and ranged from 36.8% in Gauteng to 52.8% in Eastern Cape. Individuals who were older, women, formerly married, black, obese, consumed a medium amount of sugary drinks, received education to primary or secondary school level or exposed to smoke at work had an increased risk of multimorbidity. Province level factors including poverty, rurality and unemployment, as well as neighbourhood level poverty were associated with multimorbidity. Some evidence of residual multimorbidity clustering was observed at the neighbourhood but not province level. Therefore, strategies that aim to tackle multimorbidity should address the risk factors identified and the wider determinants of health within neighbourhoods.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
MH (Pre-doctoral Fellowship; NIHR302654) is funded by the National Institute for Health Research (NIHR). The views expressed in this publication are those of the author(s) and not necessarily those of the NIHR, NHS or the UK Department of Health and Social Care.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All participants of SADHS 2016 completed consent forms. The anonymised datasets with necessary permissions were obtained from the DHS programme (https://www.dhsprogram.com/data/) for this secondary analysis, and no further ethical clearance was required.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data availability statement
SADHS data are available to download from: https://preview.dhsprogram.com/data/available-datasets.cfm.